The Latest Cardiac and Vascular News
Cardiovascular Imaging Expert to Lead Core Lab Services in Support of Clinical Trials BOSTON, April 3, 2023 /PRNewswire/ — As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.Dr. Dai is a […]
Data to support regulatory submission and accelerate U.S. market access for the Cordella™ Pulmonary Artery (PA) Sensor Cordella™ is the first and only patient management platform to provide both critical PA pressure data, using an implanted sensor, and noninvasive vitals (blood pressure, heart rate, and weight) for comprehensive clinical management delivered in […]
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its investigational autologous and allogeneic cell therapies. The United States […]
CARLSBAD, Calif., April 03, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on April 1, 2023 that were approved by the Compensation Committee of its Board of […]
Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation into Phase 2 (Proof-of-Concept) identified Proof for successful heart remuscularization obtained Interim data on 15 patients with 800 million cells dose expected in Q2 2024 GÖTTINGEN, Germany, April 04, 2023 (GLOBE NEWSWIRE) — Repairon, a […]
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated Patients at High CV Risk with Elevated Triglycerides and Other High-Risk Characteristics as Studied in REDUCE-IT –- — Heart Disease Second Leading Cause of Death in Men and Women Aged 45 and Older in Israel […]
SOUTH SAN FRANCISCO, Calif., April 03, 2023 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2023 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2023, as a material inducement to […]
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Highlights · Generated revenue of $1.45 million in the fourth quarter of 2022 (91% growth […]
CLEARWATER, Fla., April 3, 2023 /PRNewswire/ — Eleven years ago on Feb. 2, 2012, Morton Plant Hospital in Clearwater became the first hospital in the Tampa Bay area to replace a heart valve without open heart surgery. The structural heart team, led by Joshua Rovin, MD, FACS, cardiovascular surgeon and medical director of The Center for Advanced Valve and […]
SANTA CLARA, Calif., April 3, 2023 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, commented on the recent Centers for Medicare and Medicaid Services (CMS) 2024 Medicare Advantage and Part D Final Rate Announcement. “Semler Scientific remains confident that screening […]
